WeVote
Log In

Bill

Bill

LC 4144

Interim study on the effects and regulation of kratom

2025 Regular Session

Montana authorizes an interim legislative study to examine kratom's effects and determine appropriate state regulatory approaches.

(LC) Draft Delivered to Requester
#alcoholanddrugs #crimes #legislature #interimstudies
0
WeVote Research Nonpartisan
Bill Summary · LC 4144

Legislative bill overview

LC 4144 is a Montana bill that directs the legislature to conduct an interim study examining the effects of kratom and how it should be regulated within the state. The study would investigate kratom's pharmacological properties, health impacts, potential for abuse, and appropriate regulatory frameworks. This is a preliminary legislative measure rather than direct regulation—it authorizes investigation and fact-finding before any potential regulatory action.

Why is this important

Kratom regulation is increasingly contested across states as the plant's popularity grows. Montana lacks a clear regulatory stance on kratom, creating uncertainty for consumers, vendors, and law enforcement. The findings from this interim study could inform future legislation that either restricts kratom access, establishes quality standards, or leaves it unregulated—decisions with significant consequences for public health policy and the kratom market.

Potential points of contention

  • Scientific uncertainty: Kratom's health effects remain debated in medical literature, with claims ranging from pain relief benefits to addiction risks; the study's conclusions will depend heavily on which evidence is prioritized
  • Federalism and commerce: Kratom sits in regulatory gray areas between federal and state authority; decisions could conflict with interstate commerce or federal positions
  • Industry interests: Kratom vendors and suppliers may oppose findings leading to restrictions, while public health advocates may push for regulation regardless of evidence quality

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.